The Multiple Myeloma Research Foundation, Inc. mission is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. To achieve this purpose, four goals are pursued. Funding research in the field of multiple myeloma, building collaborations among researchers and industry, providing disease and treatment related information to patients and family members while advocating for optimal patient care, and raising awareness of multiple myeloma.
Organization Mission Statements and About Us information are provided by GuideStar.
.@theMMRF praises the @US_FDA approval of Novartis' Farydak (panobinostat) for #multiplemyeloma patients http://t.co/Lm40nufCRM 16 Minutes Ago
.@theMMRF praises the @US_FDA approval of Novartis' Farydak (panobinostat) for #multiplemyeloma patients http://t.co/VzlhPi9axD 1 Hour Ago
.@theMMRF praises the @US_FDA approval of Novartis' Farydak (panobinostat) for #multiplemyeloma patients http://t.co/6To3MXclpK 2 Hours Ago
Organizations Recommended For You
Org Name
Duis non faucibus orci. Quisque in egestas ipsum. Morbi elementum nisl nisi, eget egestas ipsum varius ac. Nullam accumsan dolor sed malesuada mattis. Cras convallis metus dui, eu posuere tellus hendrerit in. Sed leo augue, rutrum in nunc sed, dapibus condimentum turpis.
Facebook Posts
Our Latest Tweets